AntriaBio

Investors

Press Releases

All News
By Year:
2018
2017
2016
2015
2014
2013

May 16, 2018 Rezolute Announces Appointment of Keith Vendola as Chief Financial Officer
Apr 9, 2018 Rezolute Announces Appointment of Congenital Hyperinsulinism Therapeutic Area Expert, Dr. Christine Ferrara, as Director of Clinical Development
Apr 4, 2018 Rezolute Announces Appointment of Hoyoung Huh, M.D., Ph.D. as Vice Chairman of its Board of Directors
Apr 3, 2018 Rezolute, Inc. Announces Close of Convertible Note Financing